Treatment of hypothyroidism with levothyroxine plus liothyronine: a randomized, double-blind, crossover study
Kaminski, Juliana; Miasaki, Fabíola Yukiko; Paz-Filho, Gilberto; Graf, Hans; Carvalho, Gisah Amaral de.
Arch. endocrinol. metab. (Online)
; 60(6): 562-572, Nov.-Dec. 2016. tab, graf
Artigo em Inglês |
| ID: BIBLIO-827785
Treatment of hypothyroidism with levothyroxine plus liothyronine: a randomized, double-blind, crossover study.
The pharmacodynamic equivalence of levothyroxine and liothyronine: a randomized, double blind, cross-over study in thyroidectomized patients.
Serum resistin and high sensitive CRP levels in patients with subclinical hypothyroidism before and after L-thyroxine therapy.
Defending plasma T3 is a biological priority.
Substitution of liothyronine at a 1:5 ratio for a portion of levothyroxine: effect on fatigue, symptoms of depression, and working memory versus treatment with levothyroxine alone.
Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxine.
Medically induced euthyroid hypothyroxinemia may extend survival in compassionate need cancer patients: an observational study.
Serum free triiodothyronine (T3) to free thyroxine (T4) ratio in treated central hypothyroidism compared with primary hypothyroidism and euthyroidism
Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial.
Reversible normalisation of serum TSH levels in patients with autoimmune atrophic gastritis who received L-T4 in tablet form after switching to an oral liquid formulation: a case series.